Cargando…

Apigenin, a Partial Antagonist of the Estrogen Receptor (ER), Inhibits ER-Positive Breast Cancer Cell Proliferation through Akt/FOXM1 Signaling

Approximately 80% of breast cancer (BC) cases express the estrogen receptor (ER), and 30–40% of these cases acquire resistance to endocrine therapies over time. Hyperactivation of Akt is one of the mechanisms by which endocrine resistance is acquired. Apigenin (Api), a flavone found in several plant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pham, Thu Ha, Page, Yann Le, Percevault, Frédéric, Ferrière, François, Flouriot, Gilles, Pakdel, Farzad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7796491/ https://www.ncbi.nlm.nih.gov/pubmed/33466512 http://dx.doi.org/10.3390/ijms22010470

Ejemplares similares

Deciphering the Molecular Mechanisms Sustaining the Estrogenic Activity of the Two Major Dietary Compounds Zearalenone and Apigenin in ER-Positive Breast Cancer Cell Lines
por: Lecomte, Sylvain, et al.
Publicado: (2019)

A Basic Review on Estrogen Receptor Signaling Pathways in Breast Cancer
por: Clusan, Léa, et al.
Publicado: (2023)

Unliganded Estrogen Receptor Alpha Promotes PC12 Survival during Serum Starvation
por: Ferriere, François, et al.
Publicado: (2013)

Hypoxia and ERα Transcriptional Crosstalk Is Associated with Endocrine Resistance in Breast Cancer
por: Jehanno, Charly, et al.
Publicado: (2022)

A Closer Look at Estrogen Receptor Mutations in Breast Cancer and Their Implications for Estrogen and Antiestrogen Responses
por: Clusan, Léa, et al.
Publicado: (2021)

Codon adaptation by synonymous mutations impacts the functional properties of the estrogen receptor‐alpha protein in breast cancer cells
por: Clusan, Léa, et al.
Publicado: (2023)

Differential Estrogen-Regulation of CXCL12 Chemokine Receptors, CXCR4 and CXCR7, Contributes to the Growth Effect of Estrogens in Breast Cancer Cells
por: Boudot, Antoine, et al.
Publicado: (2011)

Phytochemicals Targeting Estrogen Receptors: Beneficial Rather Than Adverse Effects?
por: Lecomte, Sylvain, et al.
Publicado: (2017)

Apigenin Attenuates the Allergic Reactions by Competitively Binding to ER With Estradiol
por: Yao, Lu, et al.
Publicado: (2020)

Glyceollins trigger anti-proliferative effects through estradiol-dependent and independent pathways in breast cancer cells
por: Lecomte, Sylvain, et al.
Publicado: (2017)

Apigenin Inhibits the Histamine-Induced Proliferation of Ovarian Cancer Cells by Downregulating ERα/ERβ Expression
por: Liu, Manman, et al.
Publicado: (2021)

Bisphenol AF Is a Full Agonist for the Estrogen Receptor ERα but a Highly Specific Antagonist for ERβ
por: Matsushima, Ayami, et al.
Publicado: (2010)

The AF-1-deficient estrogen receptor ERα46 isoform is frequently expressed in human breast tumors
por: Chantalat, Elodie, et al.
Publicado: (2016)

An Update on the Effects of Glyceollins on Human Health: Possible Anticancer Effects and Underlying Mechanisms
por: Pham, Thu Ha, et al.
Publicado: (2019)

Targeting estrogen to kill ER-positive and ER-negative breast cancer
por: Jordan, VC
Publicado: (2005)

Assessment of Xenoestrogens Using Three Distinct Estrogen Receptors and the Zebrafish Brain Aromatase Gene in a Highly Responsive Glial Cell System
por: Le Page, Yann, et al.
Publicado: (2006)

Estrogen Signaling in ERα-Negative Breast Cancer: ERβ and GPER
por: Girgert, Rainer, et al.
Publicado: (2019)

Andrographolide Inhibits ER-Positive Breast Cancer Growth and Enhances Fulvestrant Efficacy via ROS-FOXM1-ER-α Axis
por: Xu, Tong, et al.
Publicado: (2022)

Membrane estrogen receptor alpha (ERα) participates in flow-mediated dilation in a ligand-independent manner
por: Favre, Julie, et al.
Publicado: (2021)

The Co-Expression of Estrogen Receptors ERα, ERβ, and GPER in Endometrial Cancer
por: Hojnik, Marko, et al.
Publicado: (2023)

Apigenin Inhibits Growth of Breast Cancer Cells: The Role of ERα and HER2/neu
por: Scherbakov, A. M., et al.
Publicado: (2015)

Cyclopia Extracts Act as ERα Antagonists and ERβ Agonists, In Vitro and In Vivo
por: Visser, Koch, et al.
Publicado: (2013)

Molecular Pathways of Estrogen Receptor Action
por: Pakdel, Farzad
Publicado: (2018)

The Role of Estrogen Receptors in Health and Disease
por: Pakdel, Farzad
Publicado: (2023)

Functions and physiological roles of two types of estrogen receptors, ERα and ERβ, identified by estrogen receptor knockout mouse
por: Lee, Hye-Rim, et al.
Publicado: (2012)

A role for estrogen receptor alpha (ERα) and estrogen receptor beta (ERβ) in collagen biosynthesis in mouse skin
por: Markiewicz, Margaret, et al.
Publicado: (2012)

Correction: Cyclopia Extracts Act as ERα Antagonists and ERβ Agonists, In Vitro and In Vivo
por: Visser, Koch, et al.
Publicado: (2013)

Estrogen receptor (ER) was regulated by RNPC1 stabilizing mRNA in ER positive breast cancer
por: Shi, Liang, et al.
Publicado: (2015)

A tale of two estrogen receptors (ERs): how differential ER-estrogen responsive element interactions contribute to subtype-specific transcriptional responses
por: Huang, Jing, et al.
Publicado: (2006)

HOXA1 Is an Antagonist of ERα in Breast Cancer
por: Belpaire, Magali, et al.
Publicado: (2021)

Targeting newly identified ERβ/TGF‐β1/SMAD3 signals with the FDA‐approved anti‐estrogen Faslodex or an ERβ selective antagonist in renal cell carcinoma
por: Song, Wenbin, et al.
Publicado: (2018)

Honokiol is a FOXM1 antagonist
por: Halasi, Marianna, et al.
Publicado: (2018)

Detection of estrogen receptors ER-alpha and ER-beta in human ejaculated immature spermatozoa with excess residual cytoplasm
por: Rago, Vittoria, et al.
Publicado: (2006)

An estrogen receptor (ER)‐related signature in predicting prognosis of ER‐positive breast cancer following endocrine treatment
por: Tang, Jianing, et al.
Publicado: (2019)

Direct estrogen receptor (ER) / HER family crosstalk mediating sensitivity to lumretuzumab and pertuzumab in ER+ breast cancer
por: Collins, Denis, et al.
Publicado: (2017)

Forskolin Stimulates Estrogen Receptor (ER) α Transcriptional Activity and Protects ER from Degradation by Distinct Mechanisms
por: Tsai, Houng-Wei, et al.
Publicado: (2022)

Transcriptomic analysis identifies gene networks regulated by estrogen receptor α (ERα) and ERβ that control distinct effects of different botanical estrogens
por: Gong, Ping, et al.
Publicado: (2014)

HER2 and ERβ2 downregulate estrogen-responsive element-mediated transcription activity of ERα-positive cells in response to estrogen stimulation
por: Park, B-W, et al.
Publicado: (2005)

Bisphenol-C is the strongest bifunctional ERα-agonist and ERβ-antagonist due to magnified halogen bonding
por: Liu, Xiaohui, et al.
Publicado: (2021)

Characterization of Glyceollins as Novel Aryl Hydrocarbon Receptor Ligands and Their Role in Cell Migration
por: Pham, Thu Ha, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gcipuqmajmuboqoomteqlq8opd